David Passmore

1.2k total citations
24 papers, 724 citations indexed

About

David Passmore is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, David Passmore has authored 24 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in David Passmore's work include Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (7 papers) and Glycosylation and Glycoproteins Research (6 papers). David Passmore is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (7 papers) and Glycosylation and Glycoproteins Research (6 papers). David Passmore collaborates with scholars based in United States, Sweden and Germany. David Passmore's co-authors include Pina M. Cardarelli, Bishwajit Nag, M. S. Srinivasan, Amelia Black, John R. Gasdaska, Jason D. Sterling, Lynn F. Dickey, Vangipuram S. Rangan, Brian R. Clark and Suresh D. Sharma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

David Passmore

24 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Passmore United States 15 424 322 293 208 156 24 724
Bénédicte Samyn-Petit France 8 789 1.9× 165 0.5× 362 1.2× 113 0.5× 77 0.5× 8 894
Kiran Khandke United States 14 244 0.6× 294 0.9× 94 0.3× 113 0.5× 375 2.4× 24 793
Tiezheng Li United States 9 440 1.0× 376 1.2× 183 0.6× 78 0.4× 75 0.5× 17 574
A.J. Cumber United Kingdom 13 296 0.7× 199 0.6× 443 1.5× 335 1.6× 63 0.4× 19 632
Gordana Wozniak‐Knopp Austria 13 388 0.9× 333 1.0× 128 0.4× 90 0.4× 105 0.7× 46 593
Koh Amano Japan 10 347 0.8× 85 0.3× 141 0.5× 32 0.2× 202 1.3× 11 525
Ragupathy Madiyalakan United States 17 408 1.0× 231 0.7× 263 0.9× 84 0.4× 99 0.6× 32 684
Marina Ripamonti Italy 11 237 0.6× 112 0.3× 90 0.3× 88 0.4× 105 0.7× 18 467
Malaya Bhattacharya United States 14 348 0.8× 169 0.5× 149 0.5× 46 0.2× 54 0.3× 31 598
Takuo Suzuki Japan 14 493 1.2× 299 0.9× 177 0.6× 28 0.1× 98 0.6× 23 774

Countries citing papers authored by David Passmore

Since Specialization
Citations

This map shows the geographic impact of David Passmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Passmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Passmore more than expected).

Fields of papers citing papers by David Passmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Passmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Passmore. The network helps show where David Passmore may publish in the future.

Co-authorship network of co-authors of David Passmore

This figure shows the co-authorship network connecting the top 25 collaborators of David Passmore. A scholar is included among the top collaborators of David Passmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Passmore. David Passmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kotapati, Srikanth, David Passmore, Sayumi Yamazoe, et al.. (2019). Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies. Analytical Chemistry. 92(2). 2065–2073. 30 indexed citations
2.
Chowdari, Naidu S., Chin Pan, Chetana Rao, et al.. (2018). Uncialamycin as a novel payload for antibody drug conjugate (ADC) based targeted cancer therapy. Bioorganic & Medicinal Chemistry Letters. 29(3). 466–470. 25 indexed citations
3.
Liu, Ang, Alexander Kozhich, David Passmore, et al.. (2015). Quantitative bioanalysis of antibody-conjugated payload in monkey plasma using a hybrid immuno-capture LC–MS/MS approach: Assay development, validation, and a case study. Journal of Chromatography B. 1002. 54–62. 49 indexed citations
4.
Wang, Haiqing, Vangipuram S. Rangan, David Passmore, et al.. (2015). Pharmacokinetic characterization of BMS‐936561, an anti‐CD70 antibody‐drug conjugate, in preclinical animal species and prediction of its pharmacokinetics in humans. Biopharmaceutics & Drug Disposition. 37(2). 93–106. 21 indexed citations
5.
Huang, Richard Y.‐C., Ekaterina G. Deyanova, David Passmore, et al.. (2015). Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates. Journal of the American Society for Mass Spectrometry. 26(10). 1791–1794. 25 indexed citations
6.
Passmore, David, Qian Zhang, Chin Pan, et al.. (2012). Abstract LB-252: Enzymology of the mechanism of action for MDX-1203 antibody drug conjugate. Cancer Research. 72(8_Supplement). LB–252. 2 indexed citations
7.
Rao, Chetana, Chin Pan, Mary Huber, et al.. (2010). Abstract 2452: Efficacy and toxicity of an anti-CD19 antibody drug conjugate. Cancer Research. 70(8_Supplement). 2452–2452. 2 indexed citations
8.
Cardarelli, Pina M., Haichun Huang, Chin Pan, et al.. (2009). A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies. Cancer Immunology Immunotherapy. 59(2). 257–265. 39 indexed citations
9.
Pan, Chin, Jonathan Terrett, Chetana Rao, et al.. (2008). Human antibody conjugates of potential utility for prostate cancer therapy: A comparison of MGBA conjugates with antibodies targeting a cell surface target (prostate-specific membrane antigen) and an extracellular matrix target (Mindin/RG-1). Cancer Research. 68. 4062–4062. 1 indexed citations
10.
Cardarelli, Pina M., Amelia Black, David Passmore, et al.. (2008). Characterization of MDX-1401, a Human Anti-CD30 Antibody with Enhanced Effector Function, for Therapy of Malignant Lymphoma.. Blood. 112(11). 1580–1580. 1 indexed citations
11.
Sterling, Jason D., John R. Gasdaska, Amelia Black, et al.. (2006). Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nature Biotechnology. 24(12). 1591–1597. 298 indexed citations
12.
Marshall, Jason D., Christi Abbate, Priscilla Yee, et al.. (2004). Polymyxin B enhances ISS-mediated immune responses across multiple species. Cellular Immunology. 229(2). 93–105. 21 indexed citations
13.
Passmore, David, et al.. (1995). pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2. Molecular Immunology. 32(8). 555–564. 8 indexed citations
14.
Spack, Edward G., et al.. (1995). Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II: Acetylcholine receptor peptide complexes. Journal of Autoimmunity. 8(6). 787–807. 35 indexed citations
15.
Nag, Bishwajit, Hiroshi Wada, Subhashini Arimilli, et al.. (1994). The role of N-linked oligosaccharides of MHC class II antigens in T cell stimulation. Journal of Immunological Methods. 172(1). 95–104. 6 indexed citations
16.
Nag, Bishwajit, Hiroshi Wada, David Passmore, et al.. (1993). Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells. The Journal of Immunology. 150(4). 1358–1364. 29 indexed citations
17.
Nag, Bishwajit, Hidenori Wada, S.V. Deshpande, et al.. (1993). Stimulation of T cells by antigenic peptide complexed with isolated chains of major histocompatibility complex class II molecules.. Proceedings of the National Academy of Sciences. 90(4). 1604–1608. 27 indexed citations
18.
Passmore, David, et al.. (1992). Preparative-scale purification and characterization of MHC class II monomers. Journal of Immunological Methods. 155(2). 193–200. 10 indexed citations
19.
Nag, Bishwajit, David Passmore, S.V. Deshpande, & Brian R. Clark. (1992). In vitro maximum binding of antigenic peptides to murine MHC class II molecules does not always take place at the acidic pH of the in vivo endosomal compartment. The Journal of Immunology. 148(2). 369–372. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bénédicte Samyn-Petit Breakdown of academic impact, for papers by Kiran Khandke Breakdown of academic impact, for papers by Tiezheng Li Breakdown of academic impact, for papers by A.J. Cumber Breakdown of academic impact, for papers by Gordana Wozniak‐Knopp Breakdown of academic impact, for papers by Koh Amano Breakdown of academic impact, for papers by Ragupathy Madiyalakan Breakdown of academic impact, for papers by Marina Ripamonti Breakdown of academic impact, for papers by Malaya Bhattacharya Breakdown of academic impact, for papers by Takuo Suzuki
Rankless by CCL
2026